Rina-S clinical trials

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

This study is testing a new drug called Rina-S for platinum-resistant ovarian cancer. It compares Rina-S to standard chemotherapy treatments. You have an equal chance of receiving Rina-S or a standard chemotherapy. All participants receive active treatment, no placebo.